Implementation of Microcirculation Examination in Clinical Practice—Insights from the Nationwide POL-MKW Registry

Januszek, Rafał and Kołtowski, Łukasz and Tomaniak, Mariusz and Wańha, Wojciech and Wojakowski, Wojciech and Grygier, Marek and Siłka, Wojciech and Jan Horszczaruk, Grzegorz and Czarniak, Bartosz and Kręcki, Radosław and Guzik, Bartłomiej and Legutko, Jacek and Pawłowski, Tomasz and Wnęk, Paweł and Roik, Marek and Sławek-Szmyt, Sylwia and Jaguszewski, Miłosz and Roleder, Tomasz and Dziarmaga, Miłosz and Bartuś, Stanisław (2024) Implementation of Microcirculation Examination in Clinical Practice—Insights from the Nationwide POL-MKW Registry. Medicina, 60 (2). p. 277. ISSN 1648-9144

[thumbnail of medicina-60-00277.pdf] Text
medicina-60-00277.pdf - Published Version

Download (694kB)

Abstract

Background and Objectives: The assessment of coronary microcirculation may facilitate risk stratification and treatment adjustment. The aim of this study was to evaluate patients’ clinical presentation and treatment following coronary microcirculation assessment, as well as factors associated with an abnormal coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) values. Materials and Results: This retrospective analysis included 223 patients gathered from the national registry of invasive coronary microvascular testing collected between 2018 and 2023. Results: The frequency of coronary microcirculatory assessments in Poland has steadily increased since 2018. Patients with impaired IMR (≥25) were less burdened with comorbidities. Patients with normal IMR underwent revascularisation attempts more frequently (11.9% vs. 29.8%, p = 0.003). After microcirculation testing, calcium channel blockers (CCBs) and angiotensin-converting enzyme inhibitors were added more often for patients with IMR and CFR abnormalities, respectively, as compared to control groups. Moreover, patients with coronary microvascular dysfunction (CMD, defined as CFR and/or IMR abnormality), regardless of treatment choice following microcirculation assessment, were provided with trimetazidine (23.2%) and dihydropyridine CCBs (26.4%) more frequently than those without CMD who were treated conservatively (6.8%) and by revascularisation (4.2% with p = 0.002 and 0% with p < 0.001, respectively). Multivariable analysis revealed no association between angina symptoms and IMR or CFR impairment. Conclusions: The frequency of coronary microcirculatory assessments in Poland has steadily increased. Angina symptoms were not associated with either IMR or CFR impairment. After microcirculation assessment, patients with impaired microcirculation, expressed as either low CFR, high IMR or both, received additional pharmacotherapy treatment more often.

Item Type: Article
Subjects: Pustakas > Multidisciplinary
Depositing User: Unnamed user with email support@pustakas.com
Date Deposited: 06 Feb 2024 06:35
Last Modified: 06 Feb 2024 06:35
URI: http://archive.pcbmb.org/id/eprint/1845

Actions (login required)

View Item
View Item